Business
Warren Buffett bought 4 pharma giants in Q3 // Motley Fool Australia
This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.
Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) filed its Form 13F with the Securities and Exchange Commission on Monday, which gave investors a look at what the Oracle of Omaha and his team of investors bought in the third quarter.
Among the list were four pharmaceutical companies: AbbVie (NYSE: ABBV), Merck (NYSE: MRK), Bristol Myers Squibb (NYSE: BMY), and Pfizer (NYSE: PFE). The first three were similarly sized purchases of around $1.8 billion. The Pfizer purchase was substantially smaller, with a market value around $136 million.
Within the industry, there doesn’t seem to be a theme among the four drugmakers.
Merck…
-
Noosa News22 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News15 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General15 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News7 hours agoNew playground equipment encourages children to learn through ‘risky play’